Psychiatry: An SOS Call

Social policies shaped the practice of psychiatry in the past. As the discipline becomes ever more scientific, the effects of social policy on patient well-being must not be ignored.

Written byRobert E. Becker
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

© ROY SCOTT/IKON IMAGES/CORBISDuring the early 20th century American psychiatry fell under the influence of psychoanalysis. At mid-century, psychiatry broke with psychoanalysis to align more closely with scientific medicine. As psychiatry turned toward the biological sciences, state hospitals discharged thousands of severely mentally ill patients with prescriptions in hand, and federally funded mental-health initiatives, ill-prepared to cope with the deluge, sprang up in communities across the nation. This led to a split in the practice of psychiatry. For psychiatrists concerned with the brain as an entry point into a new scientific era, neurochemistry and neuropharmacology filled the void left by psychoanalysis. For psychiatrists working in the emerging community-health programs, a wide range of additional activities and their supporting sciences—sociology, psychology, and economics, as well as vocational, transcultural, and other studies—became relevant to providing improved patient care. During the ensuing years, the brain sciences flourished, while services in communities, affected by social policies, withered. Today, psychiatrists debate whether psychiatry should become an applied neuroscience focused on brain functions or a research enterprise driven by the clinical needs of patients and communities.

Clinician psychiatrists find current academic priorities and the policies that shape them unbalanced regarding which sciences and practices best serve psychiatric patients. By abruptly terminating federal funding of community services, the Reagan Administration precipitated a continuing decline in vital corollary adjuncts to psychiatric treatment. The use of drugs to manage mental disorders and the managed-care practices of insurance companies encouraged psychiatrists to abandon working in community health clinics in favor of practicing in offices. Federal policies that leave clinical drug development to industry, and the dependence on pharmaceutical companies for funding, constrained academic research. Academics and universities began to profit by selling their discoveries to such companies. Each of these developments has favored the tilt toward neuroscience and undermined psychiatry’s integration of other disciplines.

Psychiatry’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Element Bioscience Logo
Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Twist Bio 
The Scientist Placeholder Image

Seeing and Sorting with Confidence

BD

Products

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

agilent-logo

Agilent Announces the Enhanced 8850 Gas Chromatograph

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies